Meta Analysis of <scp>DHA</scp> and <scp>EPA</scp> Supplementation on Cardiovascular Outcomes and Atrial Fibrillation Risk

Sepideh Karkon Shayan, Rosull Saadoon Abbood, Sarah F. Al‐Taie, Paria Ganji Nataj, Maksudova Malika Khamdamjonovna, Siamak Aminnezhad, Yasaman Ghodsi Boushehri, Jabbarov Jamoliddin Sindorovich, Ali Sinehsepehr, Farshad Zare, Seyed Abbas Pakmehr, Elham Abdollahi, Milad Vahedinezhad

Open source

DOI: 10.1002/prp2.70265
Published: 2026-05-17
Container: Pharmacology Research & Perspectives
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/prp2.70265,
  title = {Meta Analysis of
                    <scp>DHA</scp>
                    and
                    <scp>EPA</scp>
                    Supplementation on Cardiovascular Outcomes and Atrial Fibrillation Risk},
  author = {Sepideh Karkon Shayan and Rosull Saadoon Abbood and Sarah F. Al‐Taie and Paria Ganji Nataj and Maksudova Malika Khamdamjonovna and Siamak Aminnezhad and Yasaman Ghodsi Boushehri and Jabbarov Jamoliddin Sindorovich and Ali Sinehsepehr and Farshad Zare and Seyed Abbas Pakmehr and Elham Abdollahi and Milad Vahedinezhad},
  year = {2026},
  journal = {Pharmacology Research \&amp; Perspectives},
  doi = {10.1002/prp2.70265},
  url = {https://doi.org/10.1002/prp2.70265}
}

RIS

TY  - JOUR
TI  - Meta Analysis of
                    <scp>DHA</scp>
                    and
                    <scp>EPA</scp>
                    Supplementation on Cardiovascular Outcomes and Atrial Fibrillation Risk
AU  - Sepideh Karkon Shayan
AU  - Rosull Saadoon Abbood
AU  - Sarah F. Al‐Taie
AU  - Paria Ganji Nataj
AU  - Maksudova Malika Khamdamjonovna
AU  - Siamak Aminnezhad
AU  - Yasaman Ghodsi Boushehri
AU  - Jabbarov Jamoliddin Sindorovich
AU  - Ali Sinehsepehr
AU  - Farshad Zare
AU  - Seyed Abbas Pakmehr
AU  - Elham Abdollahi
AU  - Milad Vahedinezhad
PY  - 2026
JO  - Pharmacology Research &amp; Perspectives
DO  - 10.1002/prp2.70265
UR  - https://doi.org/10.1002/prp2.70265
ER  -

APA

Shayan, S. K., Abbood, R. S., Al‐Taie, S. F., Nataj, P. G., Khamdamjonovna, M. M., Aminnezhad, S., Boushehri, Y. G., Sindorovich, J. J., Sinehsepehr, A., Zare, F., Pakmehr, S. A., Abdollahi, E., & Vahedinezhad, M. (2026). Meta Analysis of <scp>DHA</scp> and <scp>EPA</scp> Supplementation on Cardiovascular Outcomes and Atrial Fibrillation Risk. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70265

Source records

crossref · retrieved 2026-09-27T08:42:40.198Z